Logotype for Bioretec

Bioretec (BRETEC) investor relations material

Bioretec Q2 2025 earnings summary

Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.
Logotype for Bioretec
Q2 2025 earnings summary14 Aug, 2025

Executive summary

  • Completed a successful EUR 9.2 million rights issue, strengthening capital for commercialization and growth initiatives.

  • Interim CEO appointed in May 2025, with new Quality Director joining in April.

  • First European surgeries with RemeOs Trauma Screw and ramp-up of U.S. distribution partners.

  • Net sales stable year-over-year for H1 2025, but Q2 net sales declined due to one-time U.S. distribution agreement conclusion and sales channel shift.

  • R&D pipeline advanced with CE mark for RemeOs Trauma Screw and progress in U.S. regulatory submissions.

Financial highlights

  • H1 2025 net sales EUR 2,062 thousand, flat year-over-year; Q2 net sales down 51.7% to EUR 665 thousand.

  • H1 2025 sales margin (excl. other income) EUR 1,016 thousand (49.3% of net sales), down from 70.4% year-over-year.

  • H1 2025 EBITDA EUR -3,730 thousand, EBIT EUR -3,833 thousand, net loss EUR -4,801 thousand (includes EUR 1,065 thousand rights issue costs).

  • Cash and cash equivalents at period end EUR 11,467 thousand, up 190.5% year-over-year.

  • R&D spend 77.2% of total revenue in H1 2025, up from 41.4% year-over-year.

Outlook and guidance

  • Focus on accelerating commercialization of RemeOs product line and expanding U.S. and global distribution.

  • Sales margin expected to improve as direct distribution channels mature and sales volumes increase.

  • Rights issue proceeds to fund sales, marketing, R&D, and operational scaling.

Partial view of Summaries dataset, powered by Quartr API
Research faster. Power your platform.

Next Bioretec earnings date

Logotype for Bioretec
Q3 202513 Nov, 2025
Your earnings 
season toolkit.
Download
Free on both iOS & Android.

Next Bioretec earnings date

Logotype for Bioretec
Q3 202513 Nov, 2025

The essential earnings season companion

The #1 app for live earnings calls, transcripts, analyst estimates, and more. All for free.

Live calls and transcripts

Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.

Find what you need faster

Search for any keyword across all transcripts simultaneously.

Easily store key findings

Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.

Your watchlist. Your dashboard.

Follow the companies that matter to you. Get a personalized feed with real-time updates.

Be the first to know

Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.

Consensus estimates

Access analyst consensus estimates, valuation multiples, and revenue segments splits.

All IR material in one place

The easiest way to stay updated during earnings season.

Global coverage

All events from public companies. Live and recorded.

Just click and listen

No webcast links. No manual registrations.

Research anytime, anywhere

Built for professionals. Loved by everyone. Try our free mobile app.

excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
App-store-avatar.png play-store-avatar.png
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
play-store-avatar
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
App-store-avatar.png play-store-avatar.png
anuj283App Store
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
App-store-avatar.png play-store-avatar.png
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
play-store-avatar
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
App-store-avatar.png play-store-avatar.png
anuj283App Store
I can't remember the last time an app had such a positive impact on my investment process.
x-avatar
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
App-store-avatar.png play-store-avatar.png
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
x-avatar
@theshortbearx.com
I can't remember the last time an app had such a positive impact on my investment process.
x-avatar
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
App-store-avatar.png play-store-avatar.png
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
x-avatar
@theshortbearx.com

Frequently asked questions

Bioretec Oy is a medical device manufacturer based in Finland, specializing in the development, manufacturing, and commercialization of bioresorbable orthopedic implants and implant materials. These products are designed for the treatment of bone and soft tissue injuries and are utilized in various surgical applications, including pediatrics, trauma surgery, and sports surgery. The company's Activa product line includes bioabsorbable biopolymer products. Bioretec Oy also has a subsidiary in Germany, BRI.Tech GmbH, and its products are used globally. The company is headquartered in Finland, and its shares are listed on the Nasdaq Helsinki.

Quartr provides global coverage of all investor relation material from public companies.

  • Mobile app: Research anytime, anywhere with the #1 app for live earnings calls, transcripts, analyst estimates, and more. All for free.

  • Desktop (Quartr Pro): The leading platform for qualitative research, used daily by top firms and financial institutions.

  • Quartr API: Build custom solutions powered by live earnings calls, live transcripts, filings and reports, slide presentations, and more.

Yes, the Quartr mobile app is free on both iOS and Android.

Yes. Quartr provides global, industry-leading live coverage of company events such as regular earnings calls, capital markets days, M&A announcements, and investor conferences. Live with zero delays. Just click and listen.

Yes, capturing important takeaways is as simple as it gets. Even during your lunch run or commute.

Yes. Follow the companies that matter to you. Get a personalized feed with real-time updates, a tailored earnings calendar, and instant alerts when earnings calls go live.

Yes. Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned, regardless of who's talking.

Explore our global coverage